Zeus Jaren Nair

Zeus Jaren Nair

Auto-generated profile, based on publicly available information

Zeus Jaren Nair

Singapore-Massachusetts Institute of Technology Alliance for Research and Technology, Antimicrobial Resistance Interdisciplinary Research Group

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2022 in The ISME Journal
Verified
Journal Article
Open access
PDF file
JCJun-Hong Ch’nG
Jun-Hong Ch’nG
MMMugil Muthu
Mugil Muthu
KCKelvin K. L. Chong
Kelvin K. L. Chong
JWJun Jie Wong
Jun Jie Wong
CTCasandra A. Z. Tan
Casandra A. Z. Tan
KKKimberly A Kline
Kimberly A Kline
The contribution of biofilms to virulence and as a barrier to treatment is well-established for Staphylococcus aureus and Enterococcus faecalis, both nosocomial pathogens frequently isolated from biofilm-associated infections. Despite frequent co-isolation, their interactions in biofilms have not been well-characterized. We report that in combination, these two species can give rise to augmented biofilms biomass that is dependent on the activation of E. faecalis aerobic respiration. In E. faecalis, respiration requires both exogenous heme to activate the cydAB-encoded heme-dependent cytochrome bd, and the availability of O2. We determined that the ABC transporter encoded by cydDC contributes to heme import. In dual species biofilms, S. aureus provides the heme to activate E. faecalis respiration. S. aureus mutants deficient in heme biosynthesis were unable to augment biofilms whereas heme alone is sufficient to augment E. faecalis mono-species biofilms. Our results demonstrate that S. aureus-derived heme, likely in the form of released hemoproteins, promotes E. faecalis biofilm formation, and that E. faecalis gelatinase activity facilitates heme extraction from hemoproteins. This interspecies interaction and metabolic cross-feeding may explain the frequent co-occurrence of these microbes in biofilm-associated infections.

12 April 2021 in microLife
Verified
Journal Article
Open access
PDF file
IAIrina Afonina
Irina Afonina
BTBrenda Tien
Brenda Tien
ZNZeus Nair
Zeus Nair
AMArtur Matysik
Artur Matysik
LLLing Ning Lam
Ling Ning Lam
KKKimberly A Kline
Kimberly A Kline
Membrane vesicles (MVs) contribute to various biological processes in bacteria, including virulence factor delivery, antimicrobial resistance, host immune evasion and cross-species communication. MVs are frequently released from the surface of both Gram-negative and Gram-positive bacteria during growth. In some Gram-positive bacteria, genes affecting MV biogenesis have been identified, but the mechanism of MV formation is unknown. In Enterococcus faecalis, a causative agent of life-threatening bacteraemia and endocarditis, neither mechanisms of MV formation nor their role in virulence has been examined. Since MVs of many bacterial species are implicated in host–pathogen interactions, biofilm formation, horizontal gene transfer, and virulence factor secretion in other species, we sought to identify, describe and functionally characterize MVs from E. faecalis. Here, we show that E. faecalis releases MVs that possess unique lipid and protein profiles, distinct from the intact cell membrane and are enriched in lipoproteins. MVs of E. faecalis are specifically enriched in unsaturated lipids that might provide membrane flexibility to enable MV formation, providing the first insights into the mechanism of MV formation in this Gram-positive organism.

25 March 2024 in Molecular Microbiology
Verified
Journal Article
Open access
ZNZeus Jaren Nair
Zeus Jaren Nair
IGIris Hanxing Gao
Iris Hanxing Gao
AFAslam Firras
Aslam Firras
KCKelvin Kian Long Chong
Kelvin Kian Long Chong
EHEric D. Hill
Eric D. Hill
KKKimberly A. Kline
Kimberly A. Kline
Daptomycin is a last‐line antibiotic commonly used to treat vancomycin‐resistant Enterococci, but resistance evolves rapidly and further restricts already limited treatment options. While genetic determinants associated with clinical daptomycin resistance (DAPR) have been described, information on factors affecting the speed of DAPRacquisition is limited. The multiple peptide resistance factor (MprF), a phosphatidylglycerol‐modifying enzyme involved in cationic antimicrobial resistance, is linked to DAPRin pathogens such as methicillin‐resistantStaphylococcus aureus. SinceEnterococcus faecalisencodes two paralogs ofmprFand clinical DAPRmutations do not map tomprF, we hypothesized that functional redundancy between the paralogs preventsmprF‐mediated resistance and masks other evolutionary pathways to DAPR. Here, we performed in vitro evolution to DAPRinmprFmutant background. We discovered that the absence ofmprFresults in slowed DAPRevolution and is associated with inactivating mutations inftsH, resulting in the depletion of the chaperone repressor HrcA. We also report thatftsHis essential in the parental, but not in the ΔmprF, strain where FtsH depletion results in growth impairment in the parental strain, a phenotype associated with reduced extracellular acidification and reduced ability for metabolic reduction. This presents FtsH and HrcA as enticing targets for developing anti‐resistance strategies.

21 April 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CCCristina Colomer-Winter
Cristina Colomer-Winter
ZNZeus J. Nair
Zeus J. Nair
JCJerome Y. J. Chua
Jerome Y. J. Chua
SJSoukayna Jabli
Soukayna Jabli
MRMélanie Roch
Mélanie Roch
KKKimberly A. Kline
Kimberly A. Kline
Daptomycin is a last resort antibiotic used to treat vancomycin-resistant enterococcal infections, but daptomycin resistance (DAP R ) arises quickly during treatment. Resistance is due to sequential acquisition of point mutations in the two-component system LiaFSR and in cardiolipin synthases and is associated with alteration of phospholipid and glycolipid membrane composition. The molecular mechanisms underlying these lipid changes are currently unknown. Similarly, it is unclear why mutations in liaFSR occur prior to mutations in cls . We found that Enterococcus faecalis remodels membrane composition as a phenotypic response to daptomycin that parallels the membrane composition of DAP R strains. The enrichment in glycolipids that follows antibiotic exposure is due to LtaS1, the main lipoteichoic acid (LTA) synthase of E. faecalis . LTA production is primarily governed by LiaFSR and SapRS, which directly couples antibiotic sensing with membrane lipid remodeling. Together, our results provide a unifying mechanism that drives phenotypic membrane fortification in a gram-positive pathogen which simultaneously predisposes the cell to acquire genetic high-level daptomycin resistance.

31 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ZNZeus Jaren Nair
Zeus Jaren Nair
IGIris Hanxing Gao
Iris Hanxing Gao
AFAslam Firras
Aslam Firras
KCKelvin Kian Long Chong
Kelvin Kian Long Chong
PCPei Yi Choo
Pei Yi Choo
KKKimberly A. Kline
Kimberly A. Kline
Summary: Daptomycin is a last-line antibiotic commonly used to treat vancomycin resistant Enterococci, but resistance evolves rapidly and further restricts already limited treatment options. While genetic determinants associated with clinical daptomycin resistance (DAP R ) have been described, information on factors affecting the speed of DAP R acquisition is limited. The multiple peptide resistance factor (MprF), a phosphatidylglycerol modifying enzyme involved in cationic antimicrobial resistance, is linked to DAP R in pathogens such as methicillin-resistant Staphylococcus aureus . Since Enterococcus faecalis encodes two paralogs of mprF and clinical DAP R mutations do not map to mprF, we hypothesized that functional redundancy between the paralogs prevents mprF -mediated resistance and masks other evolutionary pathways to DAP R . Here we performed in vitro evolution to DAP R in mprF mutant background. We discovered that the absence of mprF results in slowed DAP R evolution and is associated with inactivating mutations in ftsH resulting in the depletion of the chaperone repressor HrcA. We also report that ftsH is essential in the parental, but not in the Δ mprF , strain where FtsH depletion results in growth impairment in the parental strain, a phenotype associated with reduced glycolysis and reduced ability for metabolic reduction. This presents FtsH and HrcA as enticing targets for developing anti-resistance strategies. Graphical

17 November 2025 in bioRxiv
Verified
Preprint
Open access
CCCristina Colomer-Winter
Cristina Colomer-Winter
ZNZeus J. Nair
Zeus J. Nair
JCJerome Y. J. Chua
Jerome Y. J. Chua
SJSoukayna Jabli
Soukayna Jabli
MRMélanie Roch
Mélanie Roch
KKKimberly A. Kline
Kimberly A. Kline
Daptomycin is a last resort antibiotic used to treat vancomycin-resistant enterococcal infections, but daptomycin resistance (DAP R ) arises quickly during treatment. Resistance is due to sequential acquisition of point mutations in the two-component system LiaFSR and in cardiolipin synthases and is associated with alteration of phospholipid and glycolipid membrane composition. The molecular mechanisms underlying these lipid changes are currently unknown. Similarly, it is unclear why mutations in liaFSR occur prior to mutations in cls . We discovered that Enterococcus faecalis remodels membrane composition as a phenotypic response to daptomycin that parallels the membrane composition of DAP R strains. The enrichment in glycolipids that follows antibiotic exposure is due to LtaS1, the main LTA synthase of E. faecalis . Moreover, LtaS1 activity is governed by a network of two-component systems formed by LiaFSR, SapRS, and BsrRS that couple antibiotic sensing with membrane lipid remodeling. Together, our results provide a unifying mechanism that drives phenotypic membrane fortification in a Gram-positive pathogen which simultaneously predisposes the cell to acquire genetic high-level daptomycin resistance. Significance Statement: Daptomycin is the preferred alternative to treat vancomycin-resistant Enterococcus infections. However, the efficacy of daptomycin is limited by the acquisition of daptomycin resistance. Alterations in lipid membrane composition represent a conserved strategy to fortify the Gram-positive membrane. We discovered that E. faecalis phenotypically remodels membrane composition in response to daptomycin and that the enrichment in glycolipids is dependent on LTA synthesis. We expand our limited knowledge of enterococcal LTA synthases, confirming LtaS1 as the main LTA synthase and placing LTA biogenesis under control of a network of antibiotic-responsive two-component systems. Our work provides a molecular explanation for the sequential evolution of daptomycin resistance and may support the use of existing LtaS inhibitors to prevent acquisition of daptomycin resistance.